Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Not applicable Interventional Accepts healthy volunteers

A Clinical Trial to Evaluate the Effects of a Children's Daily Multivitamin on Perceived Growth, Immune Health, Energy, and Focus in Children

ClinicalTrials.gov ID: NCT07893626

Public ClinicalTrials.gov record NCT07893626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 9:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a single-group, open-label, fully decentralized (virtual) clinical trial evaluating the effects of the Hiya Kids Daily Multivitamin on parent/caregiver-perceived growth and development, immune health, daily energy, focus, and overall well-being in generally healthy children aged 3-12 years over an eight-week supplementation period. Enrolled children will receive one Hiya Kids Daily Multivitamin chewable tablet administered once daily with the first meal of the day for eight consecutive weeks. Parents or caregivers will complete study-specific questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8, and a product acceptability assessment at Week 8. All assessments are completed remotely via the study platform. Forty participants will be enrolled.

Study identification

NCT ID
NCT07893626
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Hiya Health
Industry
Enrollment
40 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Years to 12 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2026 (Actual)
Primary completion
Oct 26, 2026 (Estimated)
Completion
Oct 26, 2026 (Estimated)
Last update posted
Oct 26, 2026

2026

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Citruslabs Las Vegas Nevada 89118 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07893626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07893626 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →